PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
RMOMX
Price
$24.49
Change
+$0.28 (+1.16%)
Updated
Jul 25 closing price
Net Assets
71.28M
Interact to see
Advertisement

PMAQX vs RMOMX

Header iconPMAQX vs RMOMX Comparison
Open Charts PMAQX vs RMOMXBanner chart's image
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
Victory RS Mid Cap Growth Member
Price$24.49
Change+$0.28 (+1.16%)
VolumeN/A
Net Assets71.28M
PMAQX vs RMOMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PMAQX vs. RMOMX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMAQX is a Buy and RMOMX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. RMOMX (71.3M). PMAQX pays higher dividends than RMOMX: PMAQX (0.19) vs RMOMX (0.00). PMAQX was incepted earlier than RMOMX: PMAQX (9 years) vs RMOMX (5 years). RMOMX (2.71) is less costly to investors than PMAQX (0.59). RMOMX is a more actively managed with annual turnover of: 126.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than RMOMX: PMAQX (0) vs RMOMX (3000). RMOMX annual gain was more profitable for investors over the last year : 26.03 vs. PMAQX (13.16).
PMAQXRMOMXPMAQX / RMOMX
Total Expense Ratio0.591.0556%
Annual Report Gross Expense Ratio0.592.7122%
Fund Existence9 years5 years-
Gain YTD7.9775.906135%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets33B71.3M46,283%
Annual Yield % from dividends0.190.00-
Returns for 1 year13.1626.0351%
Returns for 3 years49.7641.83119%
Returns for 5 years57.67N/A-
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics